Document Detail


Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England.
MedLine Citation:
PMID:  21207386     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Fetal sex determination is performed for women who carry X-linked conditions, for example Duchenne muscular dystrophy (DMD), or those associated with ambiguous genitalia, for example congenital adrenal hyperplasia (CAH). Non-invasive prenatal diagnosis (NIPD) using cell-free fetal DNA (cffDNA) in maternal plasma is an alternative to invasive prenatal diagnosis (IPD), which carries a 1% risk of miscarriage. This study aimed to evaluate the incremental cost of NIPD compared with IPD of fetal sex.
METHODS: Diagnostic accuracy, invasive testing rate, and pregnancy outcome following NIPD were ascertained from an audit of all cases referred to two laboratories in 2006 to 2009. Care pathways for DMD and CAH were established and key cost drivers for IPD and NIPD identified using costs derived from published estimates and local laboratory values.
RESULTS: The differences in mean costs per pregnancy for NIPD versus IPD were small for DMD [mean difference - £87, 95% confidence interval (CI) - £303 to £131] and CAH (-£193, 95% CI - £301 to - £84). Testing costs associated with NIPD were offset by fewer women requiring invasive testing.
CONCLUSIONS: The costs of NIPD and IPD of fetal sex are similar. NIPD can provide benefits for many women by avoiding the risks of invasive testing, without incurring additional costs.
Authors:
Melissa Hill; Sally Taffinder; Lyn S Chitty; Stephen Morris
Related Documents :
21279126 - Prenatal psychology: implications for the practice of medicine.
200416 - Correlation of ovarian binding of 125i-hcg with formation of camp, estradiol and proges...
1162096 - Hormone changes occurring during second trimester abortion induced with 15 (s)-15-methy...
11228096 - Characterization of late-pregnant rat uterine contraction via the contractility ratio i...
12434116 - Large granular lymphocytes (lgls) activity in women with spontaneous abortions during t...
16150266 - Impact of maternal-fetal surgery for myelomeningocele on the progression of ventriculom...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-01-04
Journal Detail:
Title:  Prenatal diagnosis     Volume:  31     ISSN:  1097-0223     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-04     Completed Date:  2011-06-23     Revised Date:  2014-03-14    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  England    
Other Details:
Languages:  eng     Pagination:  267-73     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Hyperplasia, Congenital / blood,  diagnosis,  genetics
Blood Chemical Analysis / economics
Costs and Cost Analysis
DNA / analysis,  blood
England
Female
Fetus / metabolism
Humans
Male
Pregnancy
Pregnancy Complications / economics,  etiology
Pregnancy Outcome / economics,  epidemiology
Prenatal Diagnosis / adverse effects,  economics*,  methods*
Sex Determination Analysis / economics*,  methods*
Grant Support
ID/Acronym/Agency:
RP-PG-0707-10107//Department of Health
Chemical
Reg. No./Substance:
9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsi...
Next Document:  A predictive model of short cervix at 20-24 weeks using first-trimester cervical length measurement ...